ANI Pharmaceuticals Inc (ANIP)
65.41
-0.68
(-1.03%)
USD |
NASDAQ |
Apr 24, 16:00
65.41
0.00 (0.00%)
After-Hours: 18:43
ANI Pharmaceuticals Market Cap: 1.378B for April 24, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
April 23, 2024 | 1.392B |
April 22, 2024 | 1.382B |
April 19, 2024 | 1.380B |
April 18, 2024 | 1.361B |
April 17, 2024 | 1.380B |
April 16, 2024 | 1.381B |
April 15, 2024 | 1.397B |
April 12, 2024 | 1.409B |
April 11, 2024 | 1.435B |
April 10, 2024 | 1.411B |
April 09, 2024 | 1.413B |
April 08, 2024 | 1.424B |
April 05, 2024 | 1.425B |
April 04, 2024 | 1.431B |
April 03, 2024 | 1.417B |
April 02, 2024 | 1.406B |
April 01, 2024 | 1.430B |
March 28, 2024 | 1.456B |
March 27, 2024 | 1.468B |
March 26, 2024 | 1.465B |
March 25, 2024 | 1.466B |
March 22, 2024 | 1.466B |
March 21, 2024 | 1.460B |
March 20, 2024 | 1.436B |
March 19, 2024 | 1.430B |
Date | Value |
---|---|
March 18, 2024 | 1.425B |
March 15, 2024 | 1.390B |
March 14, 2024 | 1.392B |
March 13, 2024 | 1.395B |
March 12, 2024 | 1.402B |
March 11, 2024 | 1.393B |
March 08, 2024 | 1.420B |
March 07, 2024 | 1.405B |
March 06, 2024 | 1.386B |
March 05, 2024 | 1.377B |
March 04, 2024 | 1.399B |
March 01, 2024 | 1.415B |
February 29, 2024 | 1.426B |
February 28, 2024 | 1.270B |
February 27, 2024 | 1.263B |
February 26, 2024 | 1.269B |
February 23, 2024 | 1.246B |
February 22, 2024 | 1.225B |
February 21, 2024 | 1.180B |
February 20, 2024 | 1.195B |
February 16, 2024 | 1.222B |
February 15, 2024 | 1.178B |
February 14, 2024 | 1.148B |
February 13, 2024 | 1.126B |
February 12, 2024 | 1.167B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
292.51M
Minimum
Nov 06 2020
1.468B
Maximum
Mar 27 2024
694.38M
Average
664.47M
Median
Market Cap Benchmarks
Ligand Pharmaceuticals Inc | 1.255B |
ADMA Biologics Inc | 1.474B |
Dentsply Sirona Inc | 6.411B |
Allogene Therapeutics Inc | 513.19M |
Vanda Pharmaceuticals Inc | 262.66M |
Market Cap Related Metrics
PE Ratio | 79.77 |
PS Ratio | 2.446 |
Price to Book Value | 3.184 |
Price to Free Cash Flow | 11.85 |
Price | 65.41 |
Earnings Yield | 1.25% |
Operating PE Ratio | 24.04 |
Normalized PE Ratio | 71.42 |